Trial Search Results

Behavioral Smoking Cessation Treatment - 1

Our primary goal is to examine the effectiveness of a multi-factor maintenance treatment strategy in promoting longer-term smoking abstinence. We will also conduct secondary analyses of mediators and moderators of treatment response.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

National Institute on Drug Abuse (NIDA)

Stanford Investigator(s):

Intervention(s):

  • Behavioral: Cognitive Behavior Therapy

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Healthy adult cigarette smokers smoking at least 10 cigarettes per day

Exclusion Criteria:

   - Currently pregnant

   - Currently breastfeeding

   - Currently diagnosed with a seizure disorder, major depression, liver disease, kidney
   disease, congestive heart failure

   - History of a seizure, seizure disorder, significant head trauma or central nervous
   system tumor

   - Family history of seizures

   - Currently using intravenous drugs

   - Currently using any drugs (marijuana, alcohol, cocaine, opiates, stimulants, etc.) on
   a daily basis

   - Currently using any over-the-counter stimulants and anorectics (diet pills)

   - Currently on bupropion (Wellbutrin, Wellbutrin SR) or other antidepressants, monoamine
   oxidase inhibitors, antipsychotics, benzodiazepines, theophylline, systemic steroids
   or levodopa

   - Currently on NRT or bupropion (Zyban)

   - Current or past diagnosis of anorexia nervosa or bulimia nervosa

   - Previous allergic response to bupropion or NRT

   - Previous failed quit attempt using NRT and bupropion in combination

Ages Eligible for Study

18 Years - 65 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting